Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

April 26, 2017

The current outbreak of hepatitis E in Diffa, Niger, highlights the poor water and sanitation conditions in which the vast majority of the displaced people and refugees in the region are living.

April 25, 2017

MSF has included prevention in its malaria response for many years, initially mainly through vector control and increasing access to diagnosis and treatment.

April 24, 2017

MSF has vaccinated more than 675,000 children and cared for more than 14,000 patients in five provinces of the Democratic Republic of Congo (DRC) since November 2016.

April 06, 2017

Less than a year after the official end of the Ebola outbreak, the Guinean health system continues to struggle.

March 31, 2017

This short 360° documentary from the Financial Times follows a child with typhoid, explains how an outbreak spreads in the Democratic Republic of Congo (DRC), and how Doctors Without Borders/Médecins Sans Frontières (MSF) responds.

Use your mouse to drag the view from side to side, up and down. Or use the gray button in the top left corner of the video.

March 27, 2017

First patent opposition MSF has filed in Europe aims to increase affordable access to hepatitis C drug sofosbuvir for millions

NEW YORK/ROME/GENEVA, MARCH 27, 2017—In an effort to increase access to affordable hepatitis C treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a patent challenge on the lifesaving hepatitis C drug sofosbuvir with the European Patent Office (EPO) today.

March 24, 2017

Patients with drug-resistant tuberculosis (MDR-TB) have to take a fistful of pills and injections daily for up to two years. Side effects of these toxic drugs can include permanent deafness, nausea and vomiting, blindness, and psychosis. After decades without any new TB drugs, two powerful, less toxic medicines were finally released five years ago. But most patients can't get access to them. This needs to change.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 23, 2017

Companies and countries must take urgent action to increase access to these lifesaving treatments

March 21, 2017

Winile is a multidrug-resistant tuberculosis (MDR-TB) patient with Doctors Without Borders/Médecins Sans Frontières (MSF) in Swaziland, and one of the many who have lost their hearing due to the toxicity of available MDR-TB drugs. Through an MSF program in Swaziland, she has learned sign language so she can continue to communicate.

Pages